HeartWorks Thanks the Nelson Family: A Tribute to the Charlie’s Champs Charity Softball Tournament

A family who fundraises for HeartWorks, Charlie's Champs

At HeartWorks, our mission is centered on building stronger hearts and more memories for individuals and families affected by congenital heart defects. Recently, we had the privilege of being the beneficiary of the inaugural Charlie’s Champs Charity Softball Tournament, organized with unwavering dedication by the Nelson family.

Matthew and Alisa Nelson, alongside their community of supporters, orchestrated a remarkable event in Burbank, California, to raise funds and awareness for our cause. Their motivation stemmed from their son Charlie’s journey with Hypoplastic Left Heart Syndrome (HLHS), a condition that has shaped their lives and inspired their commitment to supporting organizations like HeartWorks. Reflecting on the event’s success, Alisa Nelson expressed, “We are so in love with how our community, family, and friends have come together to support us in this exciting venture of raising awareness and funds for CHD and research by HeartWorks.”

“We are deeply moved and grateful to the Nelson family for their extraordinary efforts in organizing the tournament,” expressed Dr. Tim Nelson, CEO and Co-Founder of HeartWorks. “Their dedication to advancing research and supporting families impacted by congenital heart defects is truly inspiring.”

The success of the tournament, which far exceeded fundraising goals and brought together numerous teams and community members, underscores the power of collective action in driving meaningful change. The Nelsons’ initiative not only raised vital funds but also fostered a sense of community spirit and solidarity among participants and spectators alike.

“The generosity and enthusiasm displayed at the tournament reaffirm our belief in the importance of collaborative efforts in improving outcomes for those affected by congenital heart defects,” Dr. Tim Nelson continued. “Events like these not only raise funds but also shine a spotlight on the resilience and determination of families facing significant health challenges.”

HeartWorks extends its heartfelt gratitude to Matthew, Alisa, and everyone involved in making the Charlie’s Champs Charity Softball Tournament a resounding success. Support like this strengthens our resolve to continue advancing research, providing support, and advocating for individuals and families affected by congenital heart defects.

For more information on HeartWorks and how you can start your own fundraiser, visit www.webuildhearts.org.

Share the Post:

Related Posts

Emma Hofmeister, Onboarding Specialist for The Co-op at HeartWorks

Supporting CHD Families Through Connection: Meet Emma Hofmeister, Onboarding Specialist for The Co-op @ HeartWorks 

Meet Emma Hofmeister, the Onboarding Specialist for The Co-op @ HeartWorks. Emma transitioned into her current role after beginning her career as a Lab Technician. For the past year and a half, her work has been multifaceted, blending community outreach with direct family support. A typical day for Emma might include presenting at a webinar to promote The Co-op, meticulously tracking records to support families, or connecting with members to answer questions about the enrollment process. She is also involved in the creation of the upcoming second Co-op journal. For Emma, the most inspiring moments are the conversations she has with heart families, whose trust and hope she says are the driving force behind the team’s mission.

Read More
HeartWorks World Headquarters in Eau Claire, WI

HeartWorks World Headquarters  |   A New Home Driving Hope for CHD Families

We’re thrilled to share an exciting milestone: the new HeartWorks World Headquarters in Eau Claire, WI! This state-of-the-art research and manufacturing facility is the heart of our mission, bringing all our teams under one roof to accelerate our life-changing work for congenital heart disease (CHD) families.

The new headquarters will dramatically increase our clinical manufacturing capacity, allowing us to produce up to 100 induced pluripotent stem cell lines per year – a significant leap from our previous capacity of 12. This expansion is critical, as it means more clinical trials, new personalized treatments, and, most importantly, more hope for those affected by CHD.

Read More

Send A Message

Name(Required)
Please let us know what's on your mind. Have a question for us? Ask away.
This field is for validation purposes and should be left unchanged.